Great West Life Assurance CO Syndax Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 20,662 shares of SNDX stock, worth $238,439. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,662
Previous 20,662
-0.0%
Holding current value
$238,439
Previous $398,000
31.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
92.7MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$98.3 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$91.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$68.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$61.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$56.3 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $653M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...